The Chemist and Druggist Stock Survey 2010 has found that many pharmacists are finding it difficult to stock branded medicines.
This in turn is hurting the health of patients, UK experts have warned. It has emerged that drugs intended for sale in the UK are being exported to take advantage of the exchange rates, forcing patients to wait for long until their prescriptions are filled.
Some of the drugs that are most difficult to obtain include Parkinson's drug Sinemet, breast cancer drug Femara, schizophrenia medicine Zyprexa and the anti-depressant Cipralexare.
The survey also said that 60% of pharmacists were braced for a worse 2011, while 90% said they spent at least one hour per week trying to find the drugs.